129 related articles for article (PubMed ID: 11851321)
1. Synthetic peptide vaccines: unexpected fulfillment of discarded hope?
Meloen RH; Langeveld JP; Schaaper WM; Slootstra JW
Biologicals; 2001; 29(3-4):233-6. PubMed ID: 11851321
[TBL] [Abstract][Full Text] [Related]
2. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
Grubman MJ
Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
[TBL] [Abstract][Full Text] [Related]
3. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
[TBL] [Abstract][Full Text] [Related]
4. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
[TBL] [Abstract][Full Text] [Related]
5. Multiple variants in foot-and-mouse disease virus (FMDV) populations: the Achilles heel for peptide and rec. DNA vaccines?
Barteling SJ; Woortmeyer R
Dev Biol Stand; 1987; 66():511-21. PubMed ID: 3034708
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D.
García-Briones MM; Blanco E; Chiva C; Andreu D; Ley V; Sobrino F
Virology; 2004 May; 322(2):264-75. PubMed ID: 15110524
[TBL] [Abstract][Full Text] [Related]
7. Past and present vaccine development strategies for the control of foot-and-mouth disease.
Balamurugan V; Kumar RM; Suryanarayana VV
Acta Virol; 2004; 48(4):201-14. PubMed ID: 15745043
[TBL] [Abstract][Full Text] [Related]
8. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.
Fowler VL; Paton DJ; Rieder E; Barnett PV
Vaccine; 2008 Apr; 26(16):1982-9. PubMed ID: 18342409
[TBL] [Abstract][Full Text] [Related]
9. Synthetic peptide vaccines: foot-and-mouth disease virus as a model.
Sobrino F; Blanco E; García-Briones M; Ley V
Dev Biol Stand; 1999; 101():39-43. PubMed ID: 10566773
[TBL] [Abstract][Full Text] [Related]
10. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
Li X; Liu R; Tang H; Jin M; Chen H; Qian P
Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
[TBL] [Abstract][Full Text] [Related]
11. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
Zheng M; Jin N; Zhang H; Jin M; Lu H; Ma M; Li C; Yin G; Wang R; Liu Q
J Virol Methods; 2006 Sep; 136(1-2):230-7. PubMed ID: 16780963
[TBL] [Abstract][Full Text] [Related]
12. Serological and mucosal immune responses after vaccination and infection with FMDV in pigs.
Eblé PL; Bouma A; Weerdmeester K; Stegeman JA; Dekker A
Vaccine; 2007 Jan; 25(6):1043-54. PubMed ID: 17157418
[TBL] [Abstract][Full Text] [Related]
13. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
Qian P; Li XM; Jin ML; Peng GQ; Chen HC
Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
[TBL] [Abstract][Full Text] [Related]
14. Foot-and-Mouth Disease Virus neutralizing antibodies production induced by pcDNA3 and Sindbis virus based plasmid encoding FMDV P1-2A3C3D in swine.
Dory D; Rémond M; Béven V; Cariolet R; Zientara S; Jestin A
Antiviral Res; 2009 Jul; 83(1):45-52. PubMed ID: 19501256
[TBL] [Abstract][Full Text] [Related]
15. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
[TBL] [Abstract][Full Text] [Related]
16. Development of synthetic peptide ELISA based on nonstructural protein 2C of foot and mouth disease virus.
Oem JK; Kye SJ; Lee KN; Park JH; Kim YJ; Song HJ; Yeh M
J Vet Sci; 2005 Dec; 6(4):317-25. PubMed ID: 16293996
[TBL] [Abstract][Full Text] [Related]
17. Serotype-specific differences in antigenic regions of foot-and-mouth disease virus (FMDV): a comprehensive statistical analysis.
Cooke JN; Westover KM
Infect Genet Evol; 2008 Dec; 8(6):855-63. PubMed ID: 18790086
[TBL] [Abstract][Full Text] [Related]
18. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs.
Eblé PL; de Bruin MG; Bouma A; van Hemert-Kluitenberg F; Dekker A
Vaccine; 2006 Feb; 24(9):1274-81. PubMed ID: 16289709
[TBL] [Abstract][Full Text] [Related]
19. DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/c mice.
Barfoed AM; Rodriguez F; Therrien D; Borrego B; Sobrino F; Kamstrup S
Antiviral Res; 2006 Dec; 72(3):178-89. PubMed ID: 16890298
[TBL] [Abstract][Full Text] [Related]
20. Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response.
Cheng G; Zhao X; Yan W; Wang W; Zuo X; Huang K; Liu Y; Chen J; Wang J; Cong W; Liu M; Gao H; Chen J; Lu Y; Zheng Z
Vaccine; 2007 Jul; 25(28):5199-208. PubMed ID: 17555848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
